Main	O
Outcomes	O
and	O
Measures	O
Primary	O
end	O
points	O
were	O
(	O
1	O
)	O
maximum	B-PrimaryOutcome
high	I-PrimaryOutcome
-	I-PrimaryOutcome
sensitivity	I-PrimaryOutcome
cardiac	I-PrimaryOutcome
troponin	I-PrimaryOutcome
level	I-PrimaryOutcome
;	O
(	O
2	O
)	O
time	B-PrimaryOutcome
for	I-PrimaryOutcome
C	I-PrimaryOutcome
-	I-PrimaryOutcome
reactive	I-PrimaryOutcome
protein	I-PrimaryOutcome
to	I-PrimaryOutcome
reach	I-PrimaryOutcome
more	I-PrimaryOutcome
than	I-PrimaryOutcome
3	I-PrimaryOutcome
times	I-PrimaryOutcome
the	I-PrimaryOutcome
upper	I-PrimaryOutcome
reference	I-PrimaryOutcome
limit	I-PrimaryOutcome
;	O
and	O
(	O
3	O
)	O
time	B-PrimaryOutcome
to	I-PrimaryOutcome
deterioration	I-PrimaryOutcome
by	I-PrimaryOutcome
2	I-PrimaryOutcome
points	I-PrimaryOutcome
on	I-PrimaryOutcome
a	I-PrimaryOutcome
7	I-PrimaryOutcome
-	I-PrimaryOutcome
grade	I-PrimaryOutcome
clinical	I-PrimaryOutcome
status	I-PrimaryOutcome
scale	I-PrimaryOutcome
,	O
ranging	O
from	O
able	O
to	O
resume	O
normal	O
activities	O
to	O
death	O
.	O

Secondary	O
end	O
points	O
were	O
(	O
1	O
)	O
the	B-SecondaryOutcome
percentage	I-SecondaryOutcome
of	I-SecondaryOutcome
participants	I-SecondaryOutcome
requiring	I-SecondaryOutcome
mechanical	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
,	O
(	O
2	O
)	O
all	B-SecondaryOutcome
-	I-SecondaryOutcome
cause	I-SecondaryOutcome
mortality	I-SecondaryOutcome
,	O
and	O
(	O
3	O
)	O
number	B-SecondaryOutcome
,	I-SecondaryOutcome
type	I-SecondaryOutcome
,	I-SecondaryOutcome
severity	I-SecondaryOutcome
,	I-SecondaryOutcome
and	I-SecondaryOutcome
seriousness	I-SecondaryOutcome
of	I-SecondaryOutcome
adverse	I-SecondaryOutcome
events	I-SecondaryOutcome
.	O

The	O
primary	O
efficacy	O
analysis	O
was	O
performed	O
on	O
an	O
intention	O
-	O
to	O
-	O
treat	O
basis	O
.	O

End	O
Points	O

Study	O
end	O
point	O
analysis	O
was	O
planned	O
to	O
be	O
performed	O
in	O
2	O
phases	O
,	O
an	O
early	O
biochemical	O
phase	O
and	O
a	O
later	O
clinical	O
phase	O
.	O

The	O
coprimary	O
end	O
points	O
of	O
the	O
biochemical	O
phase	O
were	O
the	O
difference	B-PrimaryOutcome
in	I-PrimaryOutcome
maximal	I-PrimaryOutcome
high	I-PrimaryOutcome
-	I-PrimaryOutcome
sensitivity	I-PrimaryOutcome
cardiac	I-PrimaryOutcome
troponin	I-PrimaryOutcome
(	I-PrimaryOutcome
hs	I-PrimaryOutcome
cTn	I-PrimaryOutcome
)	I-PrimaryOutcome
levels	I-PrimaryOutcome
between	I-PrimaryOutcome
the	I-PrimaryOutcome
2	I-PrimaryOutcome
groups	I-PrimaryOutcome
and	O
the	O
time	B-PrimaryOutcome
for	I-PrimaryOutcome
C	I-PrimaryOutcome
-	I-PrimaryOutcome
reactive	I-PrimaryOutcome
protein	I-PrimaryOutcome
to	I-PrimaryOutcome
reach	I-PrimaryOutcome
levels	I-PrimaryOutcome
greater	I-PrimaryOutcome
than	I-PrimaryOutcome
3	I-PrimaryOutcome
times	I-PrimaryOutcome
the	I-PrimaryOutcome
upper	I-PrimaryOutcome
reference	I-PrimaryOutcome
limit	I-PrimaryOutcome
.	O

The	O
primary	O
end	O
point	O
of	O
the	O
clinical	O
phase	O
was	O
the	O
time	B-PrimaryOutcome
from	I-PrimaryOutcome
baseline	I-PrimaryOutcome
to	I-PrimaryOutcome
clinical	I-PrimaryOutcome
deterioration	I-PrimaryOutcome
,	O
defined	O
as	O
a	O
2	B-OutcomeDefinition
-	I-OutcomeDefinition
grade	I-OutcomeDefinition
increase	I-OutcomeDefinition
on	I-OutcomeDefinition
an	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
clinical	I-OutcomeDefinition
scale	I-OutcomeDefinition
,	I-OutcomeDefinition
based	I-OutcomeDefinition
on	I-OutcomeDefinition
the	I-OutcomeDefinition
World	I-OutcomeDefinition
Health	I-OutcomeDefinition
Organization	I-OutcomeDefinition
R	I-OutcomeDefinition
&	I-OutcomeDefinition
D	I-OutcomeDefinition
Blueprint	I-OutcomeDefinition
Ordinal	I-OutcomeDefinition
Clinical	I-OutcomeDefinition
Scale	I-OutcomeDefinition
,	I-OutcomeDefinition
9	I-OutcomeDefinition
as	I-OutcomeDefinition
used	I-OutcomeDefinition
in	I-OutcomeDefinition
previously	I-OutcomeDefinition
published	I-OutcomeDefinition
studies	I-OutcomeDefinition
,	O
10	O
within	O
a	O
time	O
frame	O
of	O
3	B-TimeFrame
weeks	I-TimeFrame
after	I-TimeFrame
randomization	I-TimeFrame
or	I-TimeFrame
until	I-TimeFrame
hospital	I-TimeFrame
discharge	I-TimeFrame
(	I-TimeFrame
whichever	I-TimeFrame
occurred	I-TimeFrame
first	I-TimeFrame
)	I-TimeFrame
.	O

The	O
7	O
-	O
grade	O
ordinal	O
scale	O
consisted	O
of	O
the	O
following	O
levels	O
:	O
1	O
,	O
ambulatory	O
,	O
normal	O
activities	O
;	O
2	O
,	O
ambulatory	O
but	O
unable	O
to	O
resume	O
normal	O
activities	O
;	O
3	O
,	O
hospitalized	O
,	O
not	O
requiring	O
supplemental	O
oxygen	O
;	O
4	O
,	O
hospitalized	O
,	O
requiring	O
supplemental	O
oxygen	O
;	O
5	O
,	O
hospitalized	O
,	O
requiring	O
nasal	O
high	O
-	O
flow	O
oxygen	O
therapy	O
,	O
noninvasive	O
mechanical	O
ventilation	O
,	O
or	O
both	O
;	O
6	O
,	O
hospitalized	O
,	O
requiring	O
extracorporeal	O
membrane	O
oxygenation	O
,	O
invasive	O
mechanical	O
ventilation	O
,	O
or	O
both	O
;	O
and	O
7	O
,	O
death	O
.	O

Secondary	O
end	O
points	O
were	O
the	O
percentage	B-SecondaryOutcome
of	I-SecondaryOutcome
participants	I-SecondaryOutcome
requiring	I-SecondaryOutcome
mechanical	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
,	O
all	B-SecondaryOutcome
-	I-SecondaryOutcome
cause	I-SecondaryOutcome
mortality	I-SecondaryOutcome
at	B-TimeFrame
the	I-TimeFrame
end	I-TimeFrame
of	I-TimeFrame
follow	I-TimeFrame
-	I-TimeFrame
up	I-TimeFrame
,	O
and	O
the	O
number	B-SecondaryOutcome
,	I-SecondaryOutcome
type	I-SecondaryOutcome
,	I-SecondaryOutcome
severity	I-SecondaryOutcome
,	I-SecondaryOutcome
and	I-SecondaryOutcome
seriousness	I-SecondaryOutcome
of	I-SecondaryOutcome
total	I-SecondaryOutcome
adverse	I-SecondaryOutcome
events	I-SecondaryOutcome
and	I-SecondaryOutcome
treatment	I-SecondaryOutcome
-	I-SecondaryOutcome
related	I-SecondaryOutcome
adverse	I-SecondaryOutcome
events	I-SecondaryOutcome
.	O

